Pneumonia

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
7 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
A Gastroenterology (ATC A) 1
H Endocrinology (ATC H) 1
J Anti-infectives (ATC J) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 4 substances
Antiviral 2 substances
Unknown / small molecule 1 substance
Phase III: 1 Phase III/IV: 1 Phase I (Other): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • University Of Oxford Academic
    BALOXAVIR MARBOXIL; DEXAMETHASONE PH. EUR.; DEXAMETHASONE SODIUM PHOSPHATE; HYDROCORTISONE SODIUM SUCCINATE; OSELTAMIVIR; PREDNISOLONE
    2023-507441-29-00 9 countries 2024 n=1,590
    Recruiting

Phase III/IV

1 trial
  • Azienda Ospedaliero-Universitaria Maggiore Della Carita Academic
    COLECALCIFEROL
    2024-515978-27-00 1 country n=552
    Pending

Phase I (Other)

1 trial
  • Basilea Pharmaceutica International AG Allschwil Commercial
    IMP not specified
    2024-518592-60-00 1 country 2025 n=12
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Basilea Pharmaceutica International AG Allschwil Commercial 1 Phase I (Other) 0
Azienda Ospedaliero-Universitaria Maggiore Della Carita Academic 1 Phase III/IV 0
University Of Oxford Academic 1 Phase III 1
New trials by year
2024
1
2025
1
← All indication landscapes